Article

Study finds optic nerve pallor prevalent in ZIKA virus patients

Author(s):

Denise Freitas, MD, reports on ocular findings in infants with congenital Zika virus syndrome that were similar among the affected infants and occurred frequently.

Study finds optic nerve pallor prevalent in ZIKA virus patients

Ocular findings in infants with congenital Zika virus syndrome (CZS) were similar among the affected infants and occurred frequently, according to Denise Freitas, MD, who presented findings at the American Academy of Ophthalmology 2021 annual meeting in New Orleans.

The most prevalent of the findings was optic nerve pallor.

Freitas is from the Department of Ophthalmology and Visual Sciences, Paulista School of Medicine, Hospital São Paulo, and the Federal University of São Paulo, São Paulo, Brazil.

Freitas and colleagues conducted a study to characterize the ocular findings in infants with microcephaly and CZS from 2015 to 2017 in Paraiba, Brazil.

The investigators classified the infants into 1 of the following 3 categories: confirmed congenital ZIKV infection based on a positive test and negative for rubella, toxoplasmosis, HIV, syphilis, cytomegalovirus, and herpes simplex virus; probable congenital ZIKV infection, indicating a previous ZIKV infection or passive immunity and negative tests for the other infections; or suspected ZIKV infection in infants that did not undergo testing for ZIKV or other disease but exhibited clinical findings suggestive of the congenital ZIKV syndrome, Freitas explained.


Findings in study infants

Fifty-six infants were included in the study, all of whom had microcephaly and other signs that are typical of CZS.

The mean age at examination was 5.25 months (median, 4 months; range, 1-12 months).

The mean head circumference was 28.76 centimeters (median, 29 centimeters; range, 25-31.9 centimeters).

Freitas reported that 12 (21.4%) infants had confirmed congenital ZIKV infection, 15 (26.8%) had probable infection, and 29 (51.8%) had suspected infection.

Ocular findings were identified in 24 infants (42.9%) of the 56 infants and included gross retinal pigmentation in 11 (45.8%), macular chorioretinal atrophy in 11 (45.8%), optic nerve hypoplasia in 1 (4.2%), optic nerve pallor in 14 (58.3%), and increased optic disc excavation in 2 (8.3%).

“The ocular findings were similar among the infants and consistent with those reported in the literature, regardless of the patients’ serologic confirmation or classification,” Freitas concluded. “The findings were identified frequently and the prevalent was optic nerve pallor.”

See more AAO meeting coverage

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.